Abbreviations: α-GalCer, α-galactosylceramide; DN, CD4/CD8 double negative; DP, CD4/CD8 double positive; Veh, vehicle
AbstractInvariant natural killer T (iNKT) cells develop in the thymus upon recognition of CD1d expressed on developing thymocytes. Although CD4 and CD8 coreceptors are not directly involved in the interaction between CD1d and the T cell receptors (TCRs) of iNKT cells, a conspicuous lack of CD8 + iNKT cells in mice raised the question of whether CD8 + iNKT cells are excluded due to negative selection during their thymic development, or if there is no lineage commitment for the development of murine CD8 + iNKT cells. To address this question, we analyzed iNKT cell-specific TCR Vα14 + transgenic mice, where the Vα14 transgene forces the generation of iNKT cells. This allows detailed study of the iNKT cell repertoire. We were able to identify CD8 + iNKT cells which respond to the NKT cell-specific glycolipid ligand α-galactosylceramide. Unlike conventional iNKT cells, CD8 + iNKT cells produce predominantly IFN-γ but not IL-4 upon antigen stimulation. We also confirmed the presence of CD8 + iNKT cells in wild type mice. Our results suggest that CD8 + NKT cells do exist in mice, although their population size is quite small. Their Th1-skewed phenotype might explain why the population size of this subtype needs to be controlled tightly.